RHOEN-KLINIKUM O.N. (RHK) 12.6 EUR (%) | Healthcare & Biotech XETRA

German group operating in the management of hospitals and private clinics, providing specialized medical care.

Comment

Performance & Momentum

6 Months 1.50 %

1 Year 7.60 %

3 Years 0.69 %

5 Years 16.89 %

Momentum

Unlock this indicator

Strategic Analysis

Rhoen-Klinikum is a German private healthcare player focused on operating hospitals and specialized clinics. Its business model is based on highly operationally intensive medical services, with exposure to care volumes, quality of treatment, and the optimization of hospital capacity.

Strengths

Defensive positioning linked to a non-cyclical healthcare activity
Presence in specialized and hospital care, which supports the value of the clinical network
Embedded in the German healthcare system, a mature and well-structured market

Weaknesses

Profitability potentially sensitive to labor, regulatory, and hospital operating costs
Weak stock market track record over the medium term, reflecting limited value creation

Momentum

Momentum appears moderately positive, with recent improvement that contrasts with an still-fragile trajectory over one year and the long term. For investors, this suggests a stock in a stabilization phase rather than in a firmly established uptrend, with appeal mainly on the defensive side if operational execution continues to improve.

Analysis performed 1 month ago